Skip to content

Clinical application of FL-091 radionuclide imaging in diagnosis and staging of malignant tumors

Clinical application of FL-091 radionuclide imaging in diagnosis and staging of malignant tumors

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500113089
Enrollment
Unknown
Registered
2025-11-24
Start date
2024-10-15
Completion date
Unknown
Last updated
2025-12-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malignant tumors such as head and neck cancer, colorectal cancer, or pancreatic cancer that overexpresses NTSR1

Interventions

Gold Standard:Serum-related tumor markers, ultrasound, CT, MRI imaging data, and histopathological examinations.
Index test:68Ga-FL-091 or 111In-FL-091 radionuclide imaging.

Sponsors

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.The subject or his legal representative was able to sign the informed consent form; 2.Commit to abide by research procedures and cooperate with the implementation of the full-process research; 3.Adult patient or healthy volunteer (age 18 years or above), male or female; 4.Patients with clinically suspected or confirmed malignant tumors such as head and neck cancer, colorectal cancer and pancreatic adenocarcinoma who is generally in good condition; 5.Pathological results to be obtained by biopsy or surgical resection;

Exclusion criteria

Exclusion criteria: 1.Patient or his legal representative is unable or unwilling to sign informed consent; 2.Failure to cooperate with the implementation of full-process research; 3.Acute systemic disease and electrolyte disorders; 4.pregnant or nursing women;

Design outcomes

Primary

MeasureTime frame
SUVmax;SUVmean;T/B ratio;

Secondary

MeasureTime frame
Electrocardiogram;Immunochemical staining of biopsy/surgical tissue sections;Biochemical indicators such as blood routine, urine routine, liver and kidney functions;

Countries

China

Contacts

Public ContactXiaoli Lan

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

hzslxl@163.com+86 27 8572 6685

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026